T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQC
451
DELISTED
Equity Commonwealth
EQC
| $303M | 0.03% |
11,702,390
+2,502,566
| +27% | +$65.2M |
|
452
TechnipFMC
FTI
$29.3B
| $303M | 0.03% |
51,191,139
+6,613,094
| +15% | +$45.4M |
|
453
Euronet Worldwide
EEFT
$2.73B
| $299M | 0.03% |
2,509,055
-1,122,848
| -31% | -$133M |
|
454
Freshpet
FRPT
$3.52B
| $294M | 0.03% |
3,087,726
+231,241
| +8% | +$28.7M |
|
455
Prothena Corp
PRTA
$477M
| $294M | 0.03% |
5,948,861
-113,768
| -2% | -$6.31M |
|
456
CenterPoint Energy
CNP
$26.8B
| $294M | 0.03% |
10,519,932
+1,270,090
| +14% | +$33.9M |
|
457
Middleby
MIDD
$5.37B
| $291M | 0.03% |
1,480,632
+466,219
| +46% | +$85.1M |
|
458
SS&C Technologies
SSNC
$19B
| $291M | 0.03% |
3,543,935
-71,426
| -2% | -$5.5M |
|
|
NEE.PRP
459
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $291M | 0.03% |
5,045,733
-16,521
| -0.3% | -$899K |
|
460
CNA Financial
CNA
$13.8B
| $290M | 0.03% |
6,582,092
+194,428
| +3% | +$8.65M |
|
461
Campbell Soup
CPB
$6.93B
| $288M | 0.03% |
6,622,209
+893,638
| +16% | +$37.2M |
|
462
Option Care Health
OPCH
$3.62B
| $286M | 0.03% |
10,054,423
-460,237
| -4% | -$12.1M |
|
463
Lockheed Martin
LMT
$139B
| $285M | 0.03% |
803,154
-13,688
| -2% | -$4.73M |
|
464
Fox Class B
FOX
$24B
| $285M | 0.03% |
8,325,758
-2,819,658
| -25% | -$103M |
|
465
Helios Technologies
HLIO
$2.66B
| $283M | 0.03% |
2,695,268
-58,344
| -2% | -$5.67M |
|
466
Atmos Energy
ATO
$28.8B
| $281M | 0.03% |
2,684,929
+229,122
| +9% | +$21.7M |
|
467
Cavco Industries
CVCO
$4.62B
| $281M | 0.03% |
884,531
+34,791
| +4% | +$9.69M |
|
468
Grupo Aeroportuario del Sureste
ASR
$8.18B
| $279M | 0.03% |
1,354,599
-115,961
| -8% | -$22.9M |
|
469
Bath & Body Works
BBWI
$3.68B
| $279M | 0.03% |
3,991,743
+520,505
| +15% | +$37M |
|
|
OLPX
470
DELISTED
Olaplex Holdings
OLPX
| $277M | 0.02% |
9,515,117
+2,548,189
| +37% | +$67.6M |
|
471
Workiva
WK
$3.73B
| $276M | 0.02% |
2,116,957
-52,658
| -2% | -$7.43M |
|
472
Shoals Technologies Group
SHLS
$1.39B
| $275M | 0.02% |
11,331,120
+1,499,901
| +15% | +$43.1M |
|
473
Reynolds Consumer Products
REYN
$5.6B
| $275M | 0.02% |
8,746,158
+188,644
| +2% | +$5.5M |
|
474
PennyMac Financial
PFSI
$4.1B
| $273M | 0.02% |
3,916,901
-82,043
| -2% | -$5.41M |
|
475
Roku
ROKU
$22.7B
| $273M | 0.02% |
1,194,640
-6,007
| -0.5% | -$1.62M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.